PMS2 and colorectal carcinoma: PMS2 has been shown to play a role in DSBs, and its deficiency is associated with human dMMR in CRC.[31] PMS2 expression was nearly absent in mice treated with a combination of PRMT5i and CPT‐11, suggesting that this treatment may induce a state resembling that of dMMR in CRC (Figure 4N).